Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Silo Pharma Inc. shares valued at $354 were purchased by Weisblum Eric on Dec 20. At $2.72 per share, Weisblum Eric acquired 130 shares. The insider’s holdings grew to 154,854 shares worth approximately $0.3 million following the completion of this transaction.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Also, Weisblum Eric purchased 200 shares, netting a total of over 536 in proceeds. Following the buying of shares at $2.68 each, the insider now holds 154,724 shares.
Before that, Weisblum Eric had added 263 shares to its account. In a trade valued at $834, the CEO and President bought Silo Pharma Inc. shares for $3.17 each. Upon closing the transaction, the insider’s holdings increased to 263 shares, worth approximately $0.3 million.
Analyzing SILO Stock Performance
On Wednesday, Silo Pharma Inc. [NASDAQ: SILO] plunged -5.45% to $1.91. The stock’s lowest price that day was $1.7401, but it reached a high of $2.62 in the same session. During the last five days, there has been a drop of approximately -17.32%. Over the course of the year, Silo Pharma Inc. shares have dropped approximately -43.15%. Shares of the company reached a 52-week high of $3.98 on 02/02/23 and a 52-week low of $1.74 on 03/15/23. A 50-day SMA is recorded $2.55, while a 200-day SMA reached $4.83. Nevertheless, trading volume fell to 1.51 million shares from 17400.0 shares the previous day.
Support And Resistance Levels for Silo Pharma Inc. (SILO)
According to the 24-hour chart, there is a support level at 1.56, which, if violated, would cause prices to drop to 1.21. In the upper region, resistance lies at 2.44. The next price resistance is at 2.97. RSI (Relative Strength Index) is 30.10 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.22, which suggests the price will decrease in the coming days. Percent R is at 80.69%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Silo Pharma Inc. subject to short interest?
Stocks of Silo Pharma Inc. saw a sharp rise in short interest on Jan 12, 2023 jumping by 30960.0 shares to 56680.0. Data from Yahoo Finance shows that the short interest on Dec 14, 2022 was 25720.0 shares. A jump of 54.62% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.05 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.05.
Which companies own the most shares of Silo Pharma Inc. (SILO)?
According to Financial Advocates Investment Ma filings, the company currently owns 15,007 shares, which is about 0.48% of the total SILO shares outstanding. With the completion of the sale transaction, UBS Securities LLC’s stake is now worth $11,668. In its current portfolio, FNY Capital Management LP holds 0 shares valued at $0.0.